
High prices leave 10 000 breast cancer patients without life-saving treatment
Loading player...
More than 10 000 breast cancer patients were unable to receive treatment because of excessive prices charged by health multinational Roche. This is according to the Competition Commission, which has filed a referral to prosecute the Swiss firm.